Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
61.2M
-
Shares change
-
-8.24M
-
Total reported value, excl. options
-
$144M
-
Value change
-
-$17.8M
-
Put/Call ratio
-
0.15
-
Number of buys
-
48
-
Number of sells
-
-53
-
Price
-
$2.35
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q1 2024
130 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q1 2024.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.2M shares
of 101M outstanding shares and own 60.65% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (14.4M shares), ARMISTICE CAPITAL, LLC (7.94M shares), BlackRock Inc. (6.97M shares), VANGUARD GROUP INC (6.44M shares), ACADIAN ASSET MANAGEMENT LLC (2.5M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (2.21M shares), STATE STREET CORP (2.16M shares), GEODE CAPITAL MANAGEMENT, LLC (2.07M shares), CITADEL ADVISORS LLC (2.01M shares), and 683 Capital Management, LLC (1.85M shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.